 BOSTON, April 06, 2021 GLOBE NEWSWIRE -- Albireo Pharma, Inc. Nasdaq: ALBO, a clinical-stage rare liver disease company developing novel bile acid modulators, today announced participation in the upcoming Needham 20th Annual Healthcare Conference on April 12-15. Albireo executives taking part will include Ron Cooper, President and Chief Executive Officer and Simon Harford, Chief Financial Officer. The team will participate in a fireside chat on April 13 at 9:30 a.m. ET, which will be available on-demand on the Albireo Media Investors page at ir.albireopharma.com, as well as hosting meeting with investors throughout the conference. 